Envista Holdings Corporation (NVST) Stock Price & Analysis
Envista Holdings Corporation (NVST) closed at USD 23.97 on Thursday, October 22, 2026, up 3.36% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 23.97; the Oct 22, 2026 session ranged USD 22.9–24.02 on volume of 3,373,236 shares. Market capitalization is —, with a 52-week range of USD 18.77–30.42 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/NVST.md
Key facts (NVST)
- Last four reported quarters (through Jul 3, 2026): revenue $2.86B, net income $95.0M (3.3% margin), free cash flow $248M (SEC filings).
- 5 of 80 tracked superinvestors hold NVST (13F, Q2 2026): 0 new, 1 added, 4 reduced, 0 unchanged.
- Total return with dividends: 1Y +18.6% vs S&P 500 +14.9%; 5Y -38.6% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 0.36, revenue estimate $689M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (NVST)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $2.51B | $2.57B | $2.57B | $2.51B | $2.72B | $2.86B |
| Gross profit | $1.43B | $1.47B | $1.44B | $1.37B | $1.49B | — |
| Operating income | $306M | $319M | $31.5M | -$1.04B | $216M | $274M |
| Net income | $341M | $243M | -$100M | -$1.12B | $47.0M | $95.0M |
| EPS (diluted) | $1.92 | $1.37 | -$0.60 | -$6.50 | $0.28 | — |
| Free cash flow | $307M | $107M | $218M | $303M | $230M | $248M |
| Gross margin | 56.9% | 57.4% | 56.1% | 54.7% | 54.7% | — |
| Operating margin | 12.2% | 12.4% | 1.2% | -41.4% | 7.9% | 9.6% |
| Net margin | 13.6% | 9.5% | -3.9% | -44.6% | 1.7% | 3.3% |
| Revenue growth | +30.1% | +2.4% | -0.1% | -2.2% | +8.3% | — |
| Cash + short-term investments | $1.07B | $607M | $940M | $1.07B | $1.21B | — |
| Total debt | $1.32B | $1.38B | $1.51B | $1.39B | $1.45B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jul 3, 2026) (NVST)
P/E at fiscal year-ends: Dec 2025 78.2x.
Superinvestors (SEC 13F-HR, Q2 2026) (NVST)
5 of 80 tracked investors hold NVST. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Tweedy Browne | 2.87% | $37.8M | Reduced -0.1% | |
| John Rogers | Ariel Investments | 2.58% | $259M | Reduced -9.6% |
| Bill Nygren | Oakmark Funds | 0.10% | $72.6M | Reduced -15.5% |
| Richard Pzena | Pzena Investment Management | 0.09% | $30.5M | Reduced -27.9% |
| First Eagle Investment | First Eagle Investment Management | 0.02% | $9.8M | Added +40.8% |
Analysts (NVST)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-15 | Baird | Downgrade | Outperform → Neutral | $34 → $26 |
| 2026-10-14 | Leerink Partners | Target lowered | Outperform | $35 → $32 |
| 2026-10-09 | Piper Sandler | Target lowered | Neutral | $28 → $26 |
| 2026-09-28 | BMO Capital | Target lowered | Market Perform | $29 → $26 |
| 2026-09-18 | Piper Sandler | Reiterated | Neutral | $28 |
| 2026-09-18 | UBS | Target lowered | Neutral | $30 → $27 |
| 2026-09-18 | Needham | Reiterated | Hold | |
| 2026-09-03 | JP Morgan | Upgrade | Neutral → Overweight | $29 → $32 |
| 2026-08-06 | Piper Sandler | Target raised | Neutral | $26 → $28 |
| 2026-07-29 | Piper Sandler | Target raised | Neutral | $25 → $26 |
| 2026-07-09 | BMO Capital | Initiated | Market Perform | $27 |
Total return (dividends reinvested) (NVST)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +18.6% | -38.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +18.6% | -9.3% |
| Volatility (annualized) | 37.3% | 34.8% |
| Max drawdown | -26.0% (Feb 2026→Jun 2026) | -69.6% (Mar 2022→Apr 2025) |
NVST analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.36 | $0.34 | +3.7% | $688.8M | 15 |
| Next quarter (ends Dec 2026) | $0.41 | $0.39 | +3.5% | $753.2M | 15 |
| Current fiscal year (ends Dec 2026) | $1.53 | $1.43 | +6.9% | $2.88B | 15 |
| Next fiscal year (ends Dec 2027) | $1.66 | $1.57 | +5.6% | $2.98B | 15 |
NVST options: expected move
Options price a move of about ±15.9% (±$3.80) by Dec 18, 2026, which includes earnings on Nov 4, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Dec 18, 2026 | 56 | 47.5% | ±15.9% |
| Mar 19, 2027 | 147 | 36.4% | ±18.9% |
| Jun 17, 2027 | 237 | 45.4% | ±29.2% |
30-day implied volatility 44.4% vs 30.7% realized over the last 30 trading days. Put/call ratio (volume) —. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 23.97 |
|---|---|
| Change | ▲ 3.36% (up) |
| Previous Close | USD 23.97 |
| Open | USD 23.97 |
| Day Range | USD 22.9 – 24.02 |
| 52-Week Range | USD 18.77 – 30.42 |
| Volume | 3,373,236 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (NVST)
Nexqual's technical model rates NVST "SELL" based on 2 bullish and 4 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.8 (neutral) |
| vs SMA50 | Below (USD 25.06) |
| MACD | -0.46 (negative) |
Earnings (NVST)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD 0.36 |
| Revenue Estimate | $688.83M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.41 vs est 0.34 ▲ beat |
| 2026-03-31 | USD 0.36 vs est 0.31 ▲ beat |
| 2025-12-31 | USD 0.38 vs est 0.32 ▲ beat |
| 2025-09-30 | USD 0.32 vs est 0.28 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (NVST)
| Total Revenue | $2.86B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +7.10% |
| Gross Margin | +55.42% |
| Operating Margin | +10.39% |
| Profit Margin | +3.33% |
| ROE | +3.06% |
| Debt / Equity | 0.52 |
| Current Ratio | 2.43 |
| Total Cash | $1.13B |
| Total Debt | $1.59B |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Ownership (NVST)
| Insider Ownership | +0.59% |
|---|---|
| Institutional Ownership | +120.13% |
| Shares Outstanding | 160.62M |
| Float | 159.87M |
| Short % of Float | +8.44% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PLSE | Pulse Biosciences, Inc | USD 52.68 | ▲ 2.67% |
| ICUI | ICU Medical, Inc. | USD 168.33 | ▲ 4.66% |
| WRBY | Warby Parker Inc. | USD 25.67 | ▲ 0.16% |
| ATRC | AtriCure, Inc. | USD 59.3 | ▲ 2.83% |
| MMED | MiniMed Group, Inc. | USD 18.29 | ▲ 2.75% |
| STVN | Stevanato Group S.p.A. | USD 19.5 | ▲ 3.61% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt